{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:06:14Z","timestamp":1764785174877,"version":"3.37.3"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ovarian Cancer Association Consortium"},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","award":["PPD\/RPCI.07"],"award-info":[{"award-number":["PPD\/RPCI.07"]}],"id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U19-CA148112"],"award-info":[{"award-number":["U19-CA148112"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["076113"],"award-info":[{"award-number":["076113"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA1X01HG007491-01","U19-CA148112","R01-CA149429","R01-CA058598"],"award-info":[{"award-number":["CA1X01HG007491-01","U19-CA148112","R01-CA149429","R01-CA058598"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-86727"],"award-info":[{"award-number":["MOP-86727"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Army Medical Research and Materiel Command","award":["DAMD17-01-1-0729"],"award-info":[{"award-number":["DAMD17-01-1-0729"]}]},{"name":"National Health & Medical Research Council of Australia","award":["199600","400413","400281"],"award-info":[{"award-number":["199600","400413","400281"]}]},{"name":"Cancer Councils of New South Wales"},{"DOI":"10.13039\/501100001170","name":"Cancer Foundation of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Generally, risk stratification models for cancer use effect estimates from risk\/protective factor analyses that have not assessed potential interactions between these exposures. We have developed a 4-criterion framework for assessing interactions that includes statistical, qualitative, biological, and practical approaches. We present the application of this framework in an ovarian cancer setting because this is an important step in developing more accurate risk stratification models. Using data from 9 case-control studies in the Ovarian Cancer Association Consortium, we conducted a comprehensive analysis of interactions among 15 unequivocal risk and protective factors for ovarian cancer (including 14 non-genetic factors and a 36-variant polygenic score) with age and menopausal status. Pairwise interactions between the risk\/protective factors were also assessed. We found that menopausal status modifies the association among endometriosis, first-degree family history of ovarian cancer, breastfeeding, and depot-medroxyprogesterone acetate use and disease risk, highlighting the importance of understanding multiplicative interactions when developing risk prediction models.<\/jats:p>","DOI":"10.1093\/jnci\/djad137","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T15:08:51Z","timestamp":1689174531000},"page":"1420-1426","source":"Crossref","is-referenced-by-count":3,"title":["A framework for assessing interactions for risk stratification models: the example of ovarian cancer"],"prefix":"10.1093","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-4501","authenticated-orcid":false,"given":"Minh Tung","family":"Phung","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health , Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice W","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Public Health, California State University , Fullerton, Fullerton, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"McLean","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology and Department of Pharmacology & Therapeutics, Elm & Carlton Streets, Roswell Park Comprehensive Cancer Center , Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9603-0110","authenticated-orcid":false,"given":"Hoda","family":"Anton-Culver","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine , Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa V","family":"Bandera","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey , New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E","family":"Carney","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii , Honolulu, HI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Chang-Claude","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) , Heidelberg, Germany"},{"name":"Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf , Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W","family":"Cramer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, MA, USA"},{"name":"Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Anne","family":"Doherty","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah , Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee T","family":"Fortner","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center (DKFZ) , Heidelberg, Germany"},{"name":"Department of Research, Cancer Registry of Norway , Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc T","family":"Goodman","sequence":"additional","affiliation":[{"name":"Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center , Los Angeles, CA, USA"},{"name":"Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center , Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly R","family":"Harris","sequence":"additional","affiliation":[{"name":"Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center , Seattle, WA, USA"},{"name":"Department of Epidemiology, University of Washington School of Public Health , Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8124-4880","authenticated-orcid":false,"given":"Allan","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center , Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesmary","family":"Modugno","sequence":"additional","affiliation":[{"name":"Women\u2019s Cancer Research Center, Magee-Women\u2019s Research Institute and Hillman Cancer Center , Pittsburgh, PA, USA"},{"name":"Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine , Pittsburgh, PA, USA"},{"name":"Department of Epidemiology, University of Pittsburgh Graduate School of Public Health , Pittsburg, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B","family":"Moysich","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center , Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D P","family":"Pharoah","sequence":"additional","affiliation":[{"name":"Department of Computational Biomedicine, Cedars-Sinai Medical Centre , Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey , New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L","family":"Terry","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, MA, USA"},{"name":"Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda J","family":"Titus","sequence":"additional","affiliation":[{"name":"Public Health, Muskie School of Public Service, University of Southern Maine , Portland, ME, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope M","family":"Webb","sequence":"additional","affiliation":[{"name":"Population Health Program, QIMR Berghofer Medical Research Institute , Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna H","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California , Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-8599","authenticated-orcid":false,"given":"Nur","family":"Zeinomar","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey , New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-3727","authenticated-orcid":false,"given":"Argyrios","family":"Ziogas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Irvine , Irvine, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Duke University School of Medicine , Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen R","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School , Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian E","family":"Hanley","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of British Columbia Faculty of Medicine , Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Meza","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health , Ann Arbor, MI, USA"},{"name":"Department of Integrative Oncology, BC Cancer Research Institute , Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-4561","authenticated-orcid":false,"given":"Bhramar","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health , Ann Arbor, MI, USA"},{"name":"Department of Biostatistics, University of Michigan School of Public Health , Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm C","family":"Pike","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California , Los Angeles, CA, USA"},{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center , New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste Leigh","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan School of Public Health , Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Utah , Salt Lake City, UT, USA"},{"name":"Cancer Control and Populations Sciences Program, Huntsman Cancer Institute at the University of Utah , Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"issue":"2","key":"2023111012323659300_djad137-B1","doi-asserted-by":"publisher","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2023111012323659300_djad137-B2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","article-title":"Ovarian cancer prevention and screening","volume":"131","author":"Menon","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"9609","key":"2023111012323659300_djad137-B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"2023111012323659300_djad137-B4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1158\/1055-9965.EPI-12-1030-T","article-title":"Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer","volume":"22","author":"Pearce","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"2023111012323659300_djad137-B5","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"2023111012323659300_djad137-B6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jnci\/djaa099","article-title":"Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies","volume":"113","author":"Lee","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2023111012323659300_djad137-B7","doi-asserted-by":"publisher","first-page":"e200421","DOI":"10.1001\/jamaoncol.2020.0421","article-title":"Association between breastfeeding and ovarian cancer risk","volume":"6","author":"Babic","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"2023111012323659300_djad137-B8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/1055-9965.EPI-20-1355","article-title":"Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins","volume":"30","author":"Phung","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2023111012323659300_djad137-B9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41416-018-0011-3","article-title":"Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study","volume":"118","author":"Dixon-Suen","year":"2018","journal-title":"Br J Cancer"},{"issue":"6","key":"2023111012323659300_djad137-B10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ng.3841","article-title":"Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk","volume":"49","author":"Day","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"2023111012323659300_djad137-B11","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/ijc.30910","article-title":"Timing of births and oral contraceptive use influences ovarian cancer risk","volume":"141","author":"Wu","year":"2017","journal-title":"Int J Cancer"},{"issue":"5","key":"2023111012323659300_djad137-B12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/AOG.0000000000001387","article-title":"Association between menopausal estrogen-only therapy and ovarian carcinoma risk","volume":"127","author":"Lee","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2023111012323659300_djad137-B13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/EDE.0000000000001175","article-title":"Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored","volume":"31","author":"Lee","year":"2020","journal-title":"Epidemiology."},{"issue":"2","key":"2023111012323659300_djad137-B14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/ERC-12-0395","article-title":"Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium","volume":"20","author":"Olsen","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"2023111012323659300_djad137-B15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jmedgenet-2021-107904","article-title":"A comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors","volume":"59","author":"Lee","year":"2020","journal-title":"J Med Genet"},{"issue":"1","key":"2023111012323659300_djad137-B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-014-2905-y","article-title":"Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies","volume":"145","author":"Trentham-Dietz","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2023111012323659300_djad137-B17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"2023111012323659300_djad137-B18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6&lt;370::aid-ijc1065&gt;3.0.co;2-t","article-title":"Low-dose oral contraceptives: protective effect on ovarian cancer risk","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Cancer"},{"issue":"12","key":"2023111012323659300_djad137-B19","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s10552-012-0076-x","article-title":"Sun exposure and risk of epithelial ovarian cancer","volume":"23","author":"Bodelon","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"10","key":"2023111012323659300_djad137-B20","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10552-010-9602-x","article-title":"Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk","volume":"21","author":"Lurie","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"3","key":"2023111012323659300_djad137-B21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.annepidem.2010.10.002","article-title":"Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer","volume":"21","author":"Ness","year":"2011","journal-title":"Ann Epidemiol"},{"issue":"13","key":"2023111012323659300_djad137-B22","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1158\/0008-5472.CAN-04-3885","article-title":"Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk","volume":"65","author":"Terry","year":"2005","journal-title":"Cancer Res"},{"key":"2023111012323659300_djad137-B23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1472-6874-11-40","article-title":"Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study","volume":"11","author":"Bandera","year":"2011","journal-title":"BMC Womens Health"},{"issue":"1","key":"2023111012323659300_djad137-B24","first-page":"103","article-title":"Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer","volume":"9","author":"Ziogas","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"2023111012323659300_djad137-B25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1055-9965.EPI-15-0023","article-title":"African Americans and Hispanics remain at lower risk of ovarian cancer than non-Hispanic Whites after considering nongenetic risk factors and oophorectomy rates","volume":"24","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2023111012323659300_djad137-B26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size-or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"issue":"3-4","key":"2023111012323659300_djad137-B27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10937400701876095","article-title":"Risk factors for ovarian cancer: an overview with emphasis on hormonal factors","volume":"11","author":"Salehi","year":"2008","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"6","key":"2023111012323659300_djad137-B28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/00003495-200969060-00002","article-title":"Endometriosis: current therapies and new pharmacological developments","volume":"69","author":"Vercellini","year":"2009","journal-title":"Drugs"},{"issue":"2","key":"2023111012323659300_djad137-B29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian cancer","volume":"58","author":"Macci\u00f2","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"2023111012323659300_djad137-B30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/er.2018-00075","article-title":"Ovulation: parallels with inflammatory processes","volume":"40","author":"Duffy","year":"2019","journal-title":"Endocr Rev"},{"issue":"3","key":"2023111012323659300_djad137-B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13697137.2018.1450855","article-title":"Postmenopausal endometriosis: drawing a clearer clinical picture","volume":"21","author":"Tan","year":"2018","journal-title":"Climacteric"},{"issue":"2","key":"2023111012323659300_djad137-B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"2023111012323659300_djad137-B33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/1940-6207.CAPR-18-0383","article-title":"Phase II trial of chemopreventive effects of levonorgestrel on ovarian and fallopian tube epithelium in women at high risk for ovarian cancer: an NRG Oncology Group\/GOG study","volume":"12","author":"Rodriguez","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"2023111012323659300_djad137-B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-009-0394-1","article-title":"Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"119","author":"Milne","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2023111012323659300_djad137-B35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.gim.0000237867.34011.12","article-title":"Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention","volume":"8","author":"Ramsey","year":"2006","journal-title":"Genet Med"},{"issue":"6","key":"2023111012323659300_djad137-B36","first-page":"609","article-title":"Ovarian cancer: an overview","volume":"80","author":"Roett","year":"2009","journal-title":"Am Fam Physician."},{"issue":"113","key":"2023111012323659300_djad137-B37","first-page":"1","article-title":"Fertility of men and women aged 15-44 in the United States: national survey of family growth, 2011-2015","author":"Martinez","year":"2018","journal-title":"Natl Health Stat Rep"},{"issue":"6","key":"2023111012323659300_djad137-B38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1023\/a:1008984432272","article-title":"Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention","volume":"11","author":"Colditz","year":"2000","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2023111012323659300_djad137-B39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.ede.0000164557.81694.63","article-title":"Mathematical models of ovarian cancer incidence","volume":"16","author":"Rosner","year":"2005","journal-title":"Epidemiology"},{"issue":"5","key":"2023111012323659300_djad137-B40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/AOG.0b013e318212fcb7","article-title":"Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy","volume":"117","author":"Vitonis","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2023111012323659300_djad137-B41","doi-asserted-by":"publisher","first-page":"e1001492","DOI":"10.1371\/journal.pmed.1001492","article-title":"Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies","volume":"10","author":"Pfeiffer","year":"2013","journal-title":"PLoS Med"},{"issue":"4","key":"2023111012323659300_djad137-B42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2023111012323659300_djad137-B43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/aje\/kww091","article-title":"Risk prediction for epithelial ovarian cancer in 11 United States-based case-control studies: incorporation of epidemiologic risk factors and 17 confirmed genetic loci","volume":"184","author":"Clyde","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2023111012323659300_djad137-B44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jmedgenet-2021-107904","article-title":"Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors","volume":"59","author":"Lee","year":"2022","journal-title":"J Med Genet"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad137\/51118623\/djad137.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/11\/1420\/52934431\/djad137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/11\/1420\/52934431\/djad137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T12:33:15Z","timestamp":1699619595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/115\/11\/1420\/7223199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,7,12]]},"published-print":{"date-parts":[[2023,11,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad137","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,12]]}}}